99mTc-fanolesomab Palatin Technologies

Charito Love, Christopher J. Palestro

Research output: Contribution to journalReview articlepeer-review

26 Scopus citations


99mTc-fanolesomab is a radiolabeled imaging agent which is being developed by Palatin Technologies for use in the diagnosis of various infections, including appendicitis and osteomyelitis.

Original languageEnglish (US)
Pages (from-to)1079-1085
Number of pages7
Issue number11
StatePublished - Nov 2003
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery


Dive into the research topics of '99mTc-fanolesomab Palatin Technologies'. Together they form a unique fingerprint.

Cite this